• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR INC. ESPRIT¿; SCAFFOLD,INFRAPOPLITEAL,ABSORBABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR INC. ESPRIT¿; SCAFFOLD,INFRAPOPLITEAL,ABSORBABLE Back to Search Results
Model Number 1203250-38
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Pain (1994); Obstruction/Occlusion (2422)
Date of Event 04/09/2026
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The device was not returned for analysis.Production record and corrective and preventative actions (capa) reviews were performed and revealed no indication of a product quality issue.Additionally, a query of the complaint handling database for the reported lot revealed there is no indication of a lot specific issue.The reported patient effects of occlusion and pain are listed in the esprit btk everolimus eluting resorbable scaffold systems instructions for use (ifu) as known patient effects of scaffold procedures.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined; however, the subsequent treatment appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling; therefore, no product-related corrective action will be implemented in this case.The other two devices referenced in b5 are being filed under separate medwatch report numbers.
 
Event or Problem Description
Patient id: (b)(6).It was reported that three overlapped, esprit btk scaffolds (2.5x38 mm) were implanted on (b)(6) 2025 in the left anterior tibial artery (ata).On (b)(6) 2026, the patient presented with lifestyle-limiting claudication symptoms.The patient was found to have restenosis (occlusion) in the esprit btk scaffolds of the l ata (index limb), which required atherectomy and placement of a xience skypoint stent.Atherectomy was also performed in the posterior tibial artery (pta) to treat the chronic total occlusion of the pta.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ESPRIT¿
Common Device Name
SCAFFOLD,INFRAPOPLITEAL,ABSORBABLE
Manufacturer (Section D)
ABBOTT VASCULAR INC.
3200 lakeside drive
santa clara CA 95054 2807
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key25186318
Report Number2024168-2026-01997
Device Sequence Number18725413
Product Code NXW
UDI-Device Identifier08717648357251
UDI-Public(01)08717648357251(11)250529(17)270528(10)5052961
Combination Product (Y/N)Y
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
P230036
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Study,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 05/15/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model Number1203250-38
Device Catalogue Number1203250-38
Device Lot Number5052961
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/23/2026
Initial Report FDA Received Date05/15/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured05/29/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
2.5X38 MM ESPRIT BTK SCAFFOLDS (X2).
Outcome Attributed to Adverse Event Required Intervention; Hospitalization;
Patient Age72 YR
Patient SexFemale
Patient Weight76 KG
Patient EthnicityNon Hispanic
Patient RaceBlack Or African American
-
-